A new roadmap has been published identifying key priority areas that need to be addressed to tackle the burden of asthma. The roadmap, which has come out of the European Asthma Research and Innovation Partnership (EARIP) , suggests that a unified approach to research is urgently needed to address the challenge of asthma in Europe and improve the lives of people living with the condition.
By Elnaz Naseri, Health Policy Officer at IAPO. Depression is the leading cause of ill health and disability worldwide. [1] Alcohol-use disorder, Schizophrenia, and other mental, neurological and sub­stance-use (MNS) disorders constitute 13% of the global burden of disease surpassing both...
By Joshua Wamboga, IAPO Chair-Elect I am delighted that the Uganda Alliance of Patients’ Organizations (UAPO) will be co-hosting the key upcoming regional meeting for the International Alliance of Patients’ Organizations' (IAPO) members in Africa. The meeting which will take place in Uganda, 4-5​...
Whoever wins the Director-Generalship of the World Health Organization (WHO) faces the twin challenge of not only revamping global public health but also promoting patient-centred healthcare. While candidates are promising leadership and bold change, improving the lives of patients from all around...
This month’s policy briefing focuses on access, which is the second “key theme” of the 2017 engagement and empowerment plan . Access and support also feature amongst the five principles of the IAPO Declaration on Patient Centred Healthcare . Every patient must have access to the healthcare services...
We are pleased to announce that our side event " safety for the multi-transfused patients” has been confirmed to take place on Friday 26 May 2017 at the 70th World Health Assembly. Linked to WHA70 agenda item of “Principles for global consensus on the donation and management of blood, blood...
At the 69th World Health Assembly in Geneva in May 2016, IAPO raised the issue of access to health services by chronically ill refugees, migrants and internally displaced people. This issue will be revisited during the forthcoming World Health Assembly in Geneva, Switzerland from 22-27 May, 2017.
IAPO will take on the management of the Patient Research Exchange (PRE) platform from Novartis. This is in effort to allow IAPO member organizations to fully engage with the pharmaceutical industry through research and ‘be the change they wish to see in the pharmaceutical world!’ The Patient...
IAPO is proposing to hold four side-events with various partners this year to celebrate WHO’s contributions made over 70 years towards eradication and controlling diseases, and more importantly, marking the great contribution made by WHO in promoting patient-centred health care and improving evidence based medicine through research, policy development, technical assistance and diplomatic advocacy. The side-events will also trigger the start of patient engagement in the long march towards achieving patient-centred universal health coverage by all Member States by 2030.

Pages